230 total results
Comment
Ribociclib (Kisqali) was approved for high risk early stage breast cancer in Sept 2024. Before that...
https://connect.mayoclinic.org/comment/1287950/
Comment
Hello! I take Verzenio; it’s a CDK 4/6 inhibitor. “Verzenio is approved for women with HR+,...
Connect